modification may sterically exclude at least one water molecule out
of the five ‘‘in-plane’’ hydration sites (see discussion and Fig. S2
in ESI{).
We thank Northeastern University, The Petroleum Research
Fund, administered by the American Chemical Society (37599-
AC1) and NSF-NATO (postdoctoral fellowship DGE-0209488 to
R. S.) for support of this research. We thank Heather Brodkin,
James Glick, Dr Norman Chiu and Dr Paul Vouros for MALDI-
TOF MS analysis and Dr James Manning for help with CD
spectroscopy.
In general, the changes in hydration caused by the imidazole
modification were relatively small. For the relatively more stable
59-UG motifs 6 and 8, the imidazole modification resulted in a loss
of several water molecules per G–U base pair. For the 59-GU
motifs, imidazole modification caused either small changes (7 to 7i)
or increased the hydration (9 to 9i). It is conceivable that more
extensive hydration may contribute to higher thermal stability and
conformational rigidity of 59-UG compared to 59-GU motifs.
Interestingly, the most significant loss in thermal stability (8 to 8i)
was also accompanied by the overall largest decrease in DnW.
However, the relationship between tm and DnW was not entirely
consistent across the Table 1. More structural data will have to be
obtained on hydration of G–U pairs in different sequence contexts
to probe the role of hydration in conformation and thermal
stability of these motifs.
Notes and references
1 G. J. Narlikar and D. Herschlag, Annu. Rev. Biochem., 1997, 66, 19.
2 (a) A. Roychowdhury, H. Illangkoon, C. L. Hendrickson and
S. A. Benner, Org. Lett., 2004, 6, 489; (b) T. R. Battersby, D. N. Ang,
P. Burgstaller, S. C. Jurczyk, M. T. Bowser, D. D. Buchanan,
R. T. Kennedy and S. A. Benner, J. Am. Chem. Soc., 1999, 121, 9781;
(c) N. K. Vaish, R. Larralde, A. W. Fraley, J. W. Szostak and
L. W. McLaughlin, Biochemistry, 2003, 42, 8842; (d) N. K. Vaish,
A. W. Fraley, J. W. Szostak and L. W. McLaughlin, Nucleic Acids Res.,
2000, 28, 3316.
3 (a) S. E. Lee, A. Sidorov, H. Gourlain, N. Mignet, S. J. Thorpe,
J. A. Brazier, M. J. Dickman, D. P. Hornby, J. A. Grasby and
D. M. Williams, Nucleic Acids Res., 2001, 29, 1565; (b) T. Gourlain,
A. Sidorov, N. Mignet, S. J. Thorpe, S. E. Lee, J. A. Grasby and
D. M. Williams, Nucleic Acids Res., 2001, 29, 1898; (c) L. Lermer,
Y. Roupioz, R. Ting and D. M. Perrin, J. Am. Chem. Soc., 2002, 124,
9960; (d) D. M. Perrin, T. Garestier and C. Helene, J. Am. Chem. Soc.,
2001, 123, 1556; (e) J. D. Vaught, T. Dewey and B. E. Eaton, J. Am.
Chem. Soc., 2004, 126, 11231; (f) K. Sakthivel and C. F. Barbas III,
Angew. Chem., Int. Ed., 1998, 37, 2872.
4 (a) S. W. Santoro, G. F. Joyce, K. Sakthivel, S. Gramatikova and
C. F. Barbas III, J. Am. Chem. Soc., 2000, 122, 2433; (b) T. W. Wiegand,
R. C. Janssen and B. E. Eaton, Chem. Biol., 1997, 4, 675.
5 (a) A. J. Gutierrez, T. J. Terhorst, M. D. Matteucci and B. C. Froehler,
J. Am. Chem. Soc., 1994, 116, 5540; (b) for a recent review on palladium
assisted synthesis of nucleosides, see: L. A. Agrofoglio, I. Gillaizeau and
Y. Saito, Chem. Rev., 2003, 103, 1875.
6 M. C. Jetter and A. B. Reitz, Synthesis, 1998, 829.
7 E. Rozners, R. Renhofa, M. Petrova, Y. Popelis, V. Kumpins and
E. Bizdena, Nucleosides Nucleotides, 1992, 11, 1579.
8 (a) E. Rozners, D. Katkevica, E. Bizdena and R. Stro¨mberg, J. Am.
Chem. Soc., 2003, 125, 12125; (b) E. Rozners and R. Stro¨mberg, J. Org.
Chem., 1997, 62, 1846.
9 (a) E. Westman, S. Sigurdsson, J. Stawinski and R. Stro¨mberg, Nucleic
Acids Symp. Ser., 1994, 31, 25; (b) J. Stawinski and R. Stro¨mberg, in
Oligonucleotide Synthesis, Methods and Applications, Methods in
Molecular Biology, ed. P. Herdewijn, Humana Press, Totowa, NJ,
2005, vol. 288, ch. 6, pp. 81–100.
10 (a) X. Chen, J. A. McDowell, R. Kierzek, T. R. Krugh and
D. H. Turner, Biochemistry, 2000, 39, 8970; (b) J. A. McDowell and
D. H. Turner, Biochemistry, 1996, 35, 14077; (c) L. He, R. Kierzek,
J. SantaLucia, Jr., A. E. Walter and D. H. Turner, Biochemistry, 1991,
30, 11124.
11 (a) V. A. Parsegian, R. P. Rand and D. C. Rau, Methods Enzymol.,
1995, 259, 43; (b) C. R. Robinson and S. G. Sligar, Methods Enzymol.,
1995, 259, 395.
To gain more insight into the effect of imidazole modification
on tandem G–U wobble base pairs we compared the CD spectra
of 6–8 with 6i–8i (Fig. S3 in ESI{). Most notably, imidazole
modifications that resulted in loss of hydration in 6 and 8 (Table 1)
also caused significant changes in the CD spectra of these
sequences. For 7 and 7i, where imidazole caused the smallest
changes in tm, DG and DnW (Table 1), the CD spectra were also
similar. Thus, our results suggest that the imidazole modification
may fit best in the structurally more flexible G–U motifs, such as
59-CGUG (7), which has only one hydrogen bond per G?U base
pair according to the NMR structure.10a However, more studies
are certainly needed to confirm the generality of this observation.
In summary, our results show that 5-imidazole modification of a
G–U wobble pair is well accepted in most RNA sequence contexts,
except 8. The loss of thermal stability in 6i, 7i and 9i is relatively
small (per modification DDG0310 , 0.4 kcal mol21). The imidazole
modification also causes a small but significant rearrangement of
the hydration of RNA in 6i, 7i and 9i. Sequence 8i represents an
exception where imidazole causes a more significant loss of
thermal stability and hydration. These results suggest that
hydration effects are important to consider when designing
chemically modified nucleic acids. It is possible that the loss of
thermal stability frequently observed for non-polar modifications17
is actually due to poor hydration rather than incompatible
conformation or steric hindrance of the backbone. It is conceivable
that the imidazole modification (which is likely to be partially
protonated due to pKa in vicinity of 7) uses its hydrogen bond
donor/acceptor sites to rearrange the major groove water structure
of G–U base pairs without disrupting the overall hydration of the
duplex. In conclusion, G–U wobble pairs (and perhaps other non-
canonical base pairs as well) can be used to rationally engineer
imidazole incorporation at selected sites in RNA. This may open
new avenues for design of more active nucleic acid catalysts
(ribozymes) and receptors (aptamers) for biomedical and industrial
applications.
12 C. H. Spink and J. B. Chaires, Biochemistry, 1999, 38, 496.
13 K. J. Breslauer, Methods Enzymol., 1995, 259, 221.
14 E. Rozners and J. Moulder, Nucleic Acids Res., 2004, 32, 248.
15 E. S. Courtenay, M. W. Capp, C. F. Anderson and M. T. Record, Jr.,
Biochemistry, 2000, 39, 4455.
16 (a) P. Auffinger and E. Westhof, J. Biomol. Struct. Dyn., 1998, 16, 693;
(b) R. Biswas, M. C. Wahl, C. Ban and M. Sundaralingam, J. Mol.
Biol., 1997, 267, 1149; (c) S. R. Holbrook, C. Cheong, I. Tinoco, Jr. and
S. H. Kim, Nature, 1991, 353, 579.
17 S. M. Freier and K.-H. Altmann, Nucleic Acids Res., 1997, 25, 4429.
5780 | Chem. Commun., 2005, 5778–5780
This journal is ß The Royal Society of Chemistry 2005